Case Type: Mergers & Acquisitions

Endo, Inc. (OTC: NDOI), relating to the proposed merger with Mallinckrodt plc. Under the terms of the agreement, Endo shareholders will own 49.9% of the combined company on a pro forma basis.

2seventy bio, Inc. (NASDAQ: TSVT), relating to the proposed merger with Bristol Myers Squibb. Under the terms of the agreement, Bristol Myers Squibb will acquire 2seventy bio, with 2seventy shareholders receiving $5.00 per share in cash.

Avalon GloboCare Corp. (NASDAQ: ALBT), relating to the proposed merger with YOOV Group Holding Limited. Under the terms of the agreement, Avalon equity holders are expected to own between approximately 2.5% to 2.2% of the common stock of the combined company.

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT), relating to the proposed merger with Sun Pharmaceutical Industries Limited. Under the terms of the agreement, Checkpoint stockholders will receive, for each share of common stock they hold, a cash payment of $4.10, and a non-transferable contingent value right entitling the stockholder to receive up to $0.70 in cash.

Redfin Corporation (NASDAQ: RDFN), relating to the proposed merger with Rocket Companies. Under the terms of the agreement, Redfin shares will be converted into the right to receive 0.7926 shares of Rocket’s Class A common stock.

Blackboxstocks Inc. (NASDAQ: BLBX), relating to the proposed merger with REalloys Inc. Under the terms of the agreement, it is anticipated Blackbox’s stockholders will own approximately 7.3% of the combined company’s common stock.

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), relating to the proposed merger with Sycamore Partners. Under the terms of the agreement, WBA shareholders will receive $11.45, and one non-transferable right to receive up to $3.00, in cash, per WBA share.

Chimerix, Inc. (NASDAQ: CMRX), relating to the proposed merger with Jazz Pharmaceuticals. Under the terms of the agreement, Chimerix shareholders will receive $8.55 per share.

DT Cloud Acquisition Corporation (Nasdaq: DYCQ), relating to the proposed merger with Maius Pharmaceutical Co., Ltd. Under the terms of the agreement, shares of DT Cloud will be converted into shares of the combined company.

SolarWinds Corporation (NYSE: SWI), relating to the proposed merger with Turn/River Capital. Under the terms of the agreement, stockholders of SolarWinds will receive $18.50 per share in cash.